文献速递免疫规划卫生政策与健康促进

在加纳和莫桑比克引入和交付新型母体疫苗将花费多少?一项前瞻性分析

What will introducing and delivering new maternal vaccines cost in Ghana and Mozambique? A prospective analysis.
PubMed 文献 · Vaccine · 2025-01-31

该研究从卫生系统视角出发,采用基于活动的前瞻性成本预测方法,估算加纳和莫桑比克引入和交付母体疫苗的五年期成本。结果显示,两国均计划利用现有母体破伤风疫苗交付实践来交付新型母体疫苗;在加纳,交付一剂母体疫苗的非疫苗成本估计为3.42美元(财务成本)和4.12美元(经济成本),在莫桑比克为1.84美元(财务成本)和2.21美元(经济成本),成本以2023年美元单位表示。卫生工作者培训、沟通与社会动员以及项目规划与协调是主要成本驱动因素。

要点

  • 加纳交付一剂母体疫苗的非疫苗成本为3.42美元(财务)和4.12美元(经济)。
  • 莫桑比克交付一剂母体疫苗的非疫苗成本为1.84美元(财务)和2.21美元(经济)。
  • 卫生工作者培训、沟通与社会动员、项目规划与协调是主要成本驱动因素。

核心结论

  • 这些母体免疫成本预测与类似环境中其他新疫苗引入成本相当,为寻求了解母体免疫交付成本的本地和全球利益相关者提供了见解。

研究设计与样本

  • 采用基于活动的前瞻性成本预测方法,从卫生系统视角估算加纳和莫桑比克五年期内母体免疫引入和交付成本。
  • 国家利益相关者参与了母体免疫交付策略的制定;与关键免疫和孕产妇健康项目代表的访谈提供了关于预期卫生系统适应需求、活动和资源需求的信息。
  • 来自部分地方卫生行政单位、疫苗储存点和卫生机构的补充数据也用于成本分析;财务和经济成本以2023年美元单位估算和呈现。

主要发现

  • 两国新型母体疫苗预计将利用现有母体破伤风疫苗交付实践进行交付。
  • 加纳交付一剂母体疫苗的非疫苗成本估计为3.42美元(财务成本)和4.12美元(经济成本)。
  • 莫桑比克交付一剂母体疫苗的非疫苗成本估计为1.84美元(财务成本)和2.21美元(经济成本)。
  • 卫生工作者培训、沟通与社会动员以及项目规划与协调构成主要成本驱动因素。
  • 国家间成本差异部分由预期基线覆盖率和基线卫生系统能力差距驱动。

关键数值与推荐

  • 加纳交付一剂母体疫苗的非疫苗成本:财务成本3.42美元,经济成本4.12美元。
  • 莫桑比克交付一剂母体疫苗的非疫苗成本:财务成本1.84美元,经济成本2.21美元。
  • 成本以2023年美元单位表示。

局限性

  • 关于低收入和中等收入国家交付母体疫苗成本的研究非常少;本研究开始填补这一空白。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The maternal vaccine landscape is expanding, including the anticipated global rollout of the now approved respiratory syncytial virus maternal vaccine. Integrating maternal immunization (MI) into health systems in low-and middle-income countries (LMICs) will require adaptation to existing immunization delivery platforms and have cost implications. In this study, we project the cost of maternal vaccine introduction and delivery in Ghana and Mozambique to help inform introduction decisions and ensure financial sustainability of future MI interventions. METHODS: We used an activity-based prospective cost projection approach to estimate MI introduction and delivery costs for a five-year period from a health system perspective. Country stakeholders informed the strategies for MI delivery. Interviews with key immunization and maternal health program representatives informed on the anticipated health system adaptation requirements, activities, and resource needs taken into account in the cost projections. Supplementary data from a sample of sub-national health administrative units, vaccine stores, and health facilities also informed the costing analysis. Financial and economic costs are estimated and presented in 2023 USD units. RESULTS: New maternal vaccines in both countries are anticipated to be delivered leveraging the existing maternal tetanus vaccine delivery practices. The non-vaccine cost of delivering one dose of maternal vaccine was estimated at $3.42 (financial) and $4.12 (economic) in Ghana, and $1.84 (financial) and $2.21 (economic) in Mozambique. Health worker training, communication and social mobilization, and program planning and coordination constitute the main cost drivers. Cost differences between countries are partly driven by the anticipated baseline coverage and baseline health system capacity gaps. DISCUSSION: Very few studies exist on the costs of delivering maternal vaccine in LMICs. This study begins to fill this gap. These MI cost projections are comparable to other new vaccine introduction costs in similar settings, providing insights for local and global stakeholders seeking to understand costs of MI delivery.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Baral R, Amponsa-Achiano K, Barros I, et al. What will introducing and delivering new maternal vaccines cost in Ghana and Mozambique? A prospective analysis. Vaccine. 2025. PMID: 39892111. doi:10.1016/j.vaccine.2025.126769

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。